The effect of 2',6'-dimethyl-N(4')-benzyl- Certain derivatives of rifampicin (1-7) actively inhibit oncornavirus RNA-dependent DNA polymerase (reverse transcriptase) (8, 9) . Two rifampicin derivatives, dimethylbenzylrifampicin (DMB) and rifazacyclo-16, inhibit viral reverse transcriptase (7) and at comparable concentrations also inhibit murine sarcoma virus (MSV) transformation of mouse cells in tissue culture (10) (11) (12) (13) (14) . This correlation between biological and biochemical data suggests that these drugs block transformation by inhibiting the viral induced reverse transcriptase; alternatively the drugs may inhibit other cellular enzymes required for transformation. To further explore the latter possibility, we have compared the effect of DMB on transformation by MSV with its effect on transformation induced by simian virus 40 (SV40), a small DNA-containing virus which does not have reverse transcriptase activity. We found that SV40-induced transformation was completely normal under conditions where MSV transformation of the same cells was greatly inhibited.
Certain derivatives of rifampicin (1-7) actively inhibit oncornavirus RNA-dependent DNA polymerase (reverse transcriptase) (8, 9) . Two rifampicin derivatives, dimethylbenzylrifampicin (DMB) and rifazacyclo-16, inhibit viral reverse transcriptase (7) and at comparable concentrations also inhibit murine sarcoma virus (MSV) transformation of mouse cells in tissue culture (10) (11) (12) (13) (14) . This correlation between biological and biochemical data suggests that these drugs block transformation by inhibiting the viral induced reverse transcriptase; alternatively the drugs may inhibit other cellular enzymes required for transformation. To further explore the latter possibility, we have compared the effect of DMB on transformation by MSV with its effect on transformation induced by simian virus 40 (SV40), a small DNA-containing virus which does not have reverse transcriptase activity. We found that SV40-induced transformation was MISV Transformation. Moloney strain of murine sarcoma virus was prepared by infecting a high passage Swiss mouse embryo cell line (HPME) with a 10-2 dilution of virus stock. Details of the assay have been published (16) . Briefly, subconfluent cell monolayers were infected with MSV diluted in L15 medium with Polybrene (4 yg/ml). After 1-hr adsorption, MEM (Minimal Eagle's Medium) with 10% fetal-calf serum or complete medium was added. After 3-days incubation, the culture fluids were changed and foci of transformed cells were counted 4-6 days after infection.
RESULTS AND DISCUSSION In these experiments, DMB inhibited MSV transformation of Balb/3T3 cells to a greater extent when 1 ug/ml of amphotericin B was included in the medium (Table 1) . Previous reports (10, 13, 17) showed that DMB inhibited murine leukemia virus transformation of the mouse cell line UC1-B without the addition of amphotericin B, although it was subsequently shown that the inhibition was more reproducible and more complete when the amphotericin B was included (11) . It was hypothesized that amphotericin B acted by altering cell membrane permeability, thus enabling the DMB to be taken up more readily by the cells.
The original experiments showing murine leukemia virus focus inhibition on Balb/3T3 cells were also complicated by possible toxicity effects caused by drugs (10). Furthermore, slight toxicity which would not be apparent in a 5-day MSV assay might affect a 2-week SV40 transformation study. To avoid this problem we first selected a variant of Balb/3T3 that was resistant to 10 ,g/ml of DMB (see Materials and Methods section). The resistant cells were selected using DMB without amphotericin B. All subsequent experiments were performed with DMB plus amphotericin B.
MSV-induced foci on the resistant cells and the standard Balb/3T3 cells were compared. With the same stock of virus, both lines produced similar numbers of foci ( Table 2 ). The data in Table 2 also confirm previous observations (11) that addition of amphotericin B at a concentration of 1 jig/ml had little effect on focus formation.
The plating efficiency of the resistant cells was unaffected by 10 jg/ml of DMB plus 1 jig/ml of amphotericin B, the drug concentrations which markedly inhibited growth of the parental Balb/3T3 cells ( Table 3 ). The fact that the resistant (1974) Cell Biology: Smith and Hackett conditions, SV40 transformation was essentially unaffected by 10 jg/ml of DMB plus 1 jg/ml of amphotericin. The variations in transformation frequencies observed (Table 4) are within the reproducibility and sensitivity of SV40 transformation assays in general. For each assay, at least 80 transformants were counted and the experiment has been repeated four times with essentially the same result. The SV40 virus stock used contained 108 plaque-forming units/ml and induced a transformation frequency of 2-6% on standard Balb/3T3 cells.
These data suggest that DMB inhibits oncornavirusinduced transformation rather than nonspecifically inhibiting cellular growth or transformation. Three different lines of evidence now suggest that the DMB is specifically inhibiting the reverse transcriptase itself: (1) The concentration of DMB needed to inhibit transformation is the same order of magnitude as that needed to inhibit enzyme activity (7). (2) Under conditions where transformation is inhibited, virus production is also inhibited (12) . Recent evidence suggests that the reverse transcriptase is required for both viral production and transformation (18) . Thus, if DMB were blocking only transformation, the data would suggest that the drug was not acting on the reverse transcriptase.
(
3) The present data show that DMB specifically inhibits transformation induced by virus containing reverse transcriptase.
